Involvement of Ras-Regulated Myosin Light Chain Phosphorylation in the Captopril Effects in Spontaneously Hypertensive Rats

American Journal of Hypertension

Volumn 20, Issue 1, 2007, Pages 53-61

  Hu, Wen Yang ^a   Han, Yoo Jeong ^a   Gu, Lian Zhi ^a   Piano, Mariann ^b   de Lanerolle, Primal ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

angiotensin; Hypertension; myosin phosphorylation; signal transduction; vascular remodeling

Indexed keywords

ANGIOTENSIN II; CAPTOPRIL; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN LIGHT CHAIN; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; ENZYME REGULATION; FEMALE; HEART LEFT VENTRICLE; HEART VENTRICLE REMODELING; HEART WEIGHT; HISTOLOGY; HYPERTENSION; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SEX RATIO; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MESENTERIC ARTERIES; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; RAS PROTEINS; RATS; RATS, INBRED SHR;

EID: 33845887980     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.05.024     Document Type: Article

References (29)

1. Dzau V.J., Braun-Dullaeus R.C., and Sedding D.G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8 (2002) 1249-1256
2. de Lanerolle P., and Paul R.J. Myosin phosphorylation/dephosphorylation and regulation of airway smooth muscle contractility. Am J Physiol 261 (1991) L1-L14
3. Cai S., Pestic-Dragovich L., O'Donnell M.E., Wang N., Ingber D., Elson E., and De Lanerolle P. Regulation of cytoskeletal mechanics and cell growth by myosin light chain phosphorylation. Am J Physiol 275 (1998) C1349-C1356
4. Fazal F., Gu L., Ihnatovych I., Han Y., Hu W., Antic N., Carreira F., Blomquist J.F., Hope T.J., Ucker D.S., and de Lanerolle P. Inhibiting myosin light chain kinase induces apoptosis in vitro and in vivo. Mol Cell Biol 25 (2005) 6259-6266
5. Gu L.Z., Hu W.Y., Antic N., Mehta R., Turner J.R., and de Lanerolle P. Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells. Eur J Cancer 42 (2006) 948-957
6. Han Y.-J., Hu W.-Y., Chernaya O., Antic N., Gu L., Gupta M., Piano M., and de Lanerolle P. Increased myosin light chain kinase expression in hypertension: regulation by SRF via an insertion mutation in the promoter. Mol Biol Cell 17 (2006) 4039-4050
7. Frid M.G., Aldashev A.A., Nemenoff R.A., Higashito R., Westcott J.Y., and Stenmark K.R. Subendothelial cells from normal bovine arteries exhibit autonomous growth and constitutively activated intracellular signaling. Arterioscler Thromb Vasc Biol 19 (1999) 2884-2893
8. Moriki N., Ito M., Seko T., Kureishi Y., Okamoto R., Nakakuki T., Kongo M., Isaka N., Kaibuchi K., and Nakano T. RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Hypertens Res 27 (2004) 263-270
9. Klemke R.L., Cai S., Giannini A.L., Gallagher P.J., de Lanerolle P., and Cheresh D.A. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137 (1997) 481-492
10. Amano M., Ito M., Kimura K., Fukata Y., Chihara K., Nakano T., Matsuura Y., and Kaibuchi K. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271 (1996) 20246-20249
11. Kimura K., Ito M., Amano M., Chihara K., Fukata Y., Nakafuku M., Yamamori B., Feng J., Nakano T., Okawa K., Iwamatsu A., and Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273 (1996) 245-248
12. Fukuda N., Satoh C., Hu W.Y., Soma M., Kubo A., Kishioka H., Watanabe Y., Izumi Y., and Kanmatsuse K. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 19 (1999) 1210-1217
13. Wu J.N., and Berecek K.H. Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril. Hypertension 22 (1993) 139-146
14. Touyz R.M., and Schiffrin E.L. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52 (2000) 639-672
15. Hu W.Y., Chen D.G., Chen S.C., Jin X.Q., and Wang H.J. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats. Zhongguo Yao Li Xue Bao 17 (1996) 507-512
16. Hu W.Y., Fukuda N., Satoh C., Jian T., Kubo A., Nakayama M., Kishioka H., and Kanmatsuse K. Phenotypic modulation by fibronectin enhances the angiotensin II-generating system in cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20 (2000) 1500-1505
17. Hu W.Y., Fukuda N., and Kanmatsuse K. Growth characteristics, angiotensin II generation, and microarray-determined gene expression in vascular smooth muscle cells from young spontaneously hypertensive rats. J Hypertens 20 (2002) 1323-1333
18. Berecek K.H., Reaves P., and Raizada M. Effects of early perturbation of the renin-angiotensin system on cardiovascular remodeling in spontaneously hypertensive rats. Vascul Pharmacol 42 (2005) 93-98
19. Stier Jr. C.T. Microarray analysis of gene expression in vascular smooth muscle cells from spontaneously hypertensive rats at an early age. J Hypertens 20 (2002) 1259-1261
20. Guo D.F., Sun Y.L., Hamet P., and Inagami T. The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res 11 (2001) 165-180
21. Chen S.C., Su J.Z., Wu K., Hu W.Y., Gardner D.G., and Chen D.G. Early captopril treatment prevents hypertrophydependent gene expression in hearts of SHR. Am J Physiol 274 (1998) R1511-R1517
22. Chen D.G., Jin X.Q., Wang H.J., and Chen S.C. Mechanisms responsible for sustained hypotension after captopril treatment. J Hypertens 13 (1995) 1113-1121
23. Keuneke C., Yacullo R., Metzger R., Hellmann T., Peters J., and Ganten D. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition. Eur Heart J 11 Suppl D (1990) 11-16
24. Higashimori K., Nakamaru M., Tabuchi Y., Nagano M., Mikami H., Ogihara T., and Inagami T. Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats. Am J Hypertens 4 (1991) 56S-59S
25. Kost Jr. C.K., Li P., and Jackson E.K. Blood pressure after captopril withdrawal from spontaneously hypertensive rats. Hypertension 25 (1995) 82-87
26. Ferraz de Carvalho C.A., and Konig Jr. B. Light and electron microscopic study on the oxytalan elaunin and elastic fibers in the inferior segment of the human esophagus. Anat Anz 152 (1982) 141-157
27. Freslon J.L., and Giudicelli J.F. Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharmacol 80 (1983) 533-543
28. Peng H., Carretero O.A., Vuljaj N., Liao T.D., Motivala A., Peterson E.L., and Rhaleb N.E. Angiotensin-converting enzyme inhibitors: a new mechanism of action. Circulation 112 (2005) 2436-2445
29. Kanaide H., Ichiki T., Nishimura J., and Hirano K. Cellular mechanism of vasoconstriction induced by angiotensin II: it remains to be determined. Circ Res 93 (2003) 1015-1017